Loh Samantha M, Moloantoa Tumelo, Yende Nompumelelo, Variava Ebrahim, Niaura Raymond, Golub Jonathan E, Martinson Neil, Elf Jessica L
Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA.
Perinatal HIV Research Unit, Soweto, South Africa.
Tob Use Insights. 2023 Aug 10;16:1179173X231193890. doi: 10.1177/1179173X231193890. eCollection 2023.
Despite a high (48%) prevalence of snuff use among women with HIV in South Africa, little is known of the attitudes and behaviors of use, strategies for cessation, and potential health risks.
In a cross-sectional study, a questionnaire was administered to adults (≥18 years) with (HIV+) and without HIV (HIV-) who self-reported current snuff use to collect information on demographics, snuff use and cessation attempts, preferred strategies for cessation, other substance use, history of respiratory illness, and mental health.
150 (74 HIV+, 76 HIV-) participants were enrolled; 115 (77%) were daily snuff users, 6 (4%) were current smokers, and 17 (11%) former smokers. Top reasons for current snuff use included improving health (n = 48, 32%), reducing stress (n = 26, 16%), and "being a habit" (n = 38, 25%). Participants believed snuff use to have mostly positive (n = 68, 46%) or no (n = 54, 36%) health impacts, and 57 (38%) participants believed snuff cures headaches. 103 (69%) participants reported a previous quit attempt, and 110 (73%) indicated high interest in quitting snuff. Although 105 (70%) participants indicated that advice from a healthcare provider would aid them in quitting snuff, only 30 (20%) reported ever receiving that advice. A majority of participants (n = 141, 94%) suffer from moderate to high levels of perceived stress, and overall few differences were seen by HIV status.
Education on negative impacts of snuff, advice to quit from healthcare providers, and nicotine replacement therapy should be considered in the development of a snuff cessation program.
尽管南非感染艾滋病毒的女性中鼻烟使用率很高（48%），但对鼻烟使用的态度和行为、戒烟策略以及潜在健康风险却知之甚少。
在一项横断面研究中，对自我报告目前使用鼻烟的成年（≥18岁）艾滋病毒感染者（HIV+）和未感染艾滋病毒者（HIV-）进行问卷调查，以收集有关人口统计学、鼻烟使用和戒烟尝试、首选戒烟策略、其他物质使用、呼吸道疾病史和心理健康的信息。
共招募了150名参与者（74名HIV+，76名HIV-）；115名（77%）为每日鼻烟使用者，6名（4%）为当前吸烟者，17名（11%）为既往吸烟者。当前使用鼻烟的主要原因包括改善健康（n = 48，32%）、减轻压力（n = 26，16%）和“已成习惯”（n = 38，25%）。参与者认为鼻烟使用大多具有积极（n = 68，46%）或无（n = 54，36%）健康影响，57名（38%）参与者认为鼻烟可治愈头痛。103名（69%）参与者报告曾尝试戒烟，110名（73%）表示对戒掉鼻烟有很高兴趣。尽管105名（70%）参与者表示医疗保健提供者的建议有助于他们戒掉鼻烟，但只有30名（20%）报告曾收到过该建议。大多数参与者（n = 141，94%）有中度至高度的感知压力，总体而言，不同艾滋病毒感染状况之间差异不大。
在制定鼻烟戒烟计划时，应考虑对鼻烟负面影响的教育、医疗保健提供者的戒烟建议以及尼古丁替代疗法。
